Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 ENDOCRINE CONTROL OF PROSTATIC CANCER.

Literature DB >> 17773799

ENDOCRINE CONTROL OF PROSTATIC CANCER.

C Huggins.

Abstract

Year: 1943 PMID： 17773799 DOI： 10.1126/science.97.2529.541

Source DB: PubMed Journal: Science ISSN： 0036-8075 Impact factor: 47.728

Keyword Cloud
Cited

× No keyword cloud information.

11 in total

1. Comparison of maximal and more maximal intermittent androgen blockade during 5-year treatment of advanced prostate cancer T3NxMx-1.

Authors: Slawomir A Dutkiewicz
Journal: Int Urol Nephrol Date: 2011-09-20 Impact factor: 2.370

2. Estrogen action and prostate cancer.

Authors: Jason L Nelles; Wen-Yang Hu; Gail S Prins
Journal: Expert Rev Endocrinol Metab Date: 2011-05

3. Therapeutic Targeting of Myc.

Authors: Edward V Prochownik; Peter K Vogt
Journal: Genes Cancer Date: 2010-06

4. Pregnane X receptor as a therapeutic target to inhibit androgen activity.

Authors: Bin Zhang; Qiuqiong Cheng; Zhimin Ou; Jung Hoon Lee; Meishu Xu; Upasana Kochhar; Songrong Ren; Min Huang; Beth R Pflug; Wen Xie
Journal: Endocrinology Date: 2010-10-20 Impact factor: 4.736

Review 5. Duality of estrogen receptor β action in cancer progression.

Authors: T C Guillette; Thomas W Jackson; Scott M Belcher
Journal: Curr Opin Pharmacol Date: 2018-05-14 Impact factor: 5.547

6. Black men have lower rates than white men of biochemical failure with primary androgen-deprivation therapy.

Authors: Pejvak Sassani; Jeremy M Blumberg; T Craig Cheetham; Fang Niu; Stephen G Williams; Gary W Chien
Journal: Perm J Date: 2011

Review 7. Primitive origins of prostate cancer: in vivo evidence for prostate-regenerating cells and prostate cancer-initiating cells.

Authors: Andrew S Goldstein; Tanya Stoyanova; Owen N Witte
Journal: Mol Oncol Date: 2010-07-14 Impact factor: 6.603